BTMD · biote Corp. · Webcasts, Transcripts & Audio
$1.04
-0.19 (-15.45%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$37.36M
Shares
35.93M
Volume · Nov 5
241.04K
Avg daily vol (3M)
207.44K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
biote Corp. Webcasts
Earnings calls, investor updates, investor days and conferences for biote Corp. (BTMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-04
biote Corp. (BTMD) Q3 2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
Cautious tone
Voluntary recall and supply normalization
Procedure revenue recovery and clinic volume
Legal expenses and settlements
Revenue
$44.23M
▼ 9.5% YoY Diluted EPS
$-0.23
▼ 330% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
biote Corp. (BTMD) Q1 2026 Earnings Call Transcript
Cautious tone
Voluntary product recall
Asteria Health production recovery
Revenue and procedure volume
Revenue
$44.94M
▼ 8.3% YoY Diluted EPS
$0.06
▼ 83.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
Positive tone
Procedure revenue decline
Voluntary product recall
New clinic and practitioner growth
Revenue
$46.41M*
▼ 6.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
biote Corp. (BTMD) Q3 2025 Earnings Call Transcript
Balanced tone
Commercial team rebuild
Practitioner network and marketing event
Procedure revenue decline
Revenue
$47.96M
▼ 6.7% YoY Diluted EPS
$0.22
▼ 33.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
biote Corp. (BTMD) Q2 2025 Earnings Call Transcript
Cautious tone
Procedure revenue softness and restructuring
New clinic additions and attrition
Adjusted EBITDA and profitability
Revenue
$48.86M
▼ 0.6% YoY Diluted EPS
$0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
biote Corp. (BTMD) Q1 2025 Earnings Call Transcript
Positive tone
Procedure Revenue Decline and Recovery
Commercial Restructuring and Reorganization
Gross Margin Expansion from 503B Vertical Integration
Revenue
$48.99M
▲ 4.7% YoY Diluted EPS
$0.37
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
biote Corp. (BTMD) Q4 2024 Earnings Call Transcript
Positive tone
Clinical decision support software (CDSS) transition
Practitioner network expansion
2025 financial outlook
Revenue
$49.83M*
▲ 9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
biote Corp. (BTMD) Q3 2024 Earnings Call Transcript
Positive tone
Procedures and Clinical Decision Support software
2025 outlook and growth drivers
Vertical integration / Asteria Health manufacturing
Revenue
$51.38M
▲ 12.8% YoY Diluted EPS
$0.33
▲ 37.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
biote Corp. (BTMD) Q2 2024 Earnings Call Transcript
Positive tone
Gross margin and profitability outlook
BioteRx platform enhancements and rollout
Asteria Health integration and licensing
Revenue
$49.17M
▼ 0.2% YoY Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
biote Corp. (BTMD) Q1 2024 Earnings Call Transcript
Positive tone
BioteRx product launch
Procedure revenue growth
Practitioner training and onboarding
Revenue
$46.80M
▲ 4.4% YoY Diluted EPS
$-0.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
biote Corp. (BTMD) Q4 2023 Earnings Call Transcript
Positive tone
2024 outlook and guidance
BioteRx wellness launch
Sales force optimization and practitioner network
Revenue
$45.70M*
▲ 2.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
biote Corp. (BTMD) Q3 2023 Earnings Call Transcript
Revenue
$45.56M
▲ 8.5% YoY Diluted EPS
$0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
biote Corp. (BTMD) Q2 2023 Earnings Call Transcript
Revenue
$49.26M
▲ 19.1% YoY Diluted EPS
$-0.25
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
biote Corp. (BTMD) Q1 2023 Earnings Call
Revenue
$44.84M
▲ 20.7% YoY Diluted EPS
$-0.39
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-28
biote Corp. (BTMD) Q4 2022 Earnings Call
Revenue
$44.48M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
biote Corp. (BTMD) Q3 2022 Earnings Call
Revenue
$41.97M
▲ 18% YoY Diluted EPS
$0.00
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
biote Corp. (BTMD) Q2 2022 Earnings Call
Revenue
$41.36M
▲ 19% YoY Diluted EPS
$-0.34
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–18 of 18 webcasts
Key facts
CIK
1819253
CUSIP
090683103
13F (30d)
19 filings
12 filers
Visit website
Investor relations